相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells
Petra Gener et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors
Oliver Bechter et al.
PHARMACOLOGY & THERAPEUTICS (2020)
BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1
Dan Zong et al.
CANCER RESEARCH (2020)
Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
Mohamed Elbadawy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury
Judith Sanchez-Ventura et al.
JOURNAL OF NEUROINFLAMMATION (2019)
lBromodomain inhibitor JQ1 reversibly blocks IFN-γ production
Hunter R. Gibbons et al.
SCIENTIFIC REPORTS (2019)
BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells
Feng Li et al.
CANCER MEDICINE (2019)
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
Ana Matos et al.
JOURNAL OF CONTROLLED RELEASE (2019)
BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma
Miao Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Combinational drug-loaded lipid nanocapsules for the treatment of cancer
Nikolaos Tsakiris et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
Bernhard Mlecnik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma
Patrick L. Garcia et al.
MOLECULAR CANCER THERAPEUTICS (2018)
BET Proteins as Targets for Anticancer Treatment
Anastasios Stathis et al.
CANCER DISCOVERY (2018)
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
Bernhard Mlecnik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
JQ-1 Inhibits Colon Cancer Proliferation via Suppressing Wnt/β-Catenin Signaling and miR-21
Yan Zhang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
Diana Rafael et al.
DRUG DELIVERY (2018)
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
Fred C. Lam et al.
NATURE COMMUNICATIONS (2018)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Optimized acriflavine-loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer
Yoann Montigaud et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
Bei Zhao et al.
MELANOMA RESEARCH (2018)
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The drug delivery field at the inflection point: Time to fight its way out of the egg
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Roderik M. Kortlever et al.
CELL (2017)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Preparation and characterization of cationic Pluronic for surface modification and functionalization of polymeric drug delivery nanoparticles
G. Gyulai et al.
EXPRESS POLYMER LETTERS (2016)
OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
Caroline Berenguer-Daize et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
Mark L. McCleland et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
Yuki Kagoya et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells
Lars Togel et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery
Fernanda Andrade et al.
NANOMEDICINE (2016)
Design and characterization of bivalent BET inhibitors
Minoru Tanaka et al.
NATURE CHEMICAL BIOLOGY (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Celine Berthon et al.
LANCET HAEMATOLOGY (2016)
In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor
A. C. Groo et al.
NANOMEDICINE (2015)
BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
Emma K. Baker et al.
SCIENTIFIC REPORTS (2015)
Inhibitors of emerging epigenetic targets for cancer therapy: a patent review (2010-2014)
Minoru Tanaka et al.
PHARMACEUTICAL PATENT ANALYST (2015)
c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α
Cheng Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Role of Notch signaling in colorectal cancer
Liang Qiao et al.
CARCINOGENESIS (2009)
A novel phase inversion-based process for the preparation of lipid nanocarriers
B Heurtault et al.
PHARMACEUTICAL RESEARCH (2002)
分享论文
